Navigation Links
USC Center For Applied Molecular Medicine To Honor Sumner Redstone And Murray Gell-Mann, Ph.D. At The Inaugural REBELS WITH A CAUSE Gala

LOS ANGELES, Sept. 18, 2012 /PRNewswire/ -- USC Center for Applied Molecular Medicine honors Sumner M. Redstone and Nobel Laureate Murray Gell-Mann, Ph.D. at its REBELS WITH A CAUSE gala, September 19, 2012, at the Four Seasons Los Angeles at Beverly Hills.  The evening will raise funds to support the lifesaving research of David B. Agus, M.D., Director, USC Westside Cancer Center and USC Center for Applied Molecular Medicine.  Carmen A. Puliafito, M.D., M.B.A., Dean, Keck School of Medicine of USC is Honorary Co-Chair; Beverly and Robert Cohen Co-Chair.  The gala will feature performances by Tony Bennett and Neil Young; Tracey Ullman, emcees.

Sumner M. Redstone, Executive Chairman of Viacom and CBS Corporation has been Chairman of the Board of National Amusements since 1986, and CEO since 1967. He is a member of the Advisory Council for the ATAS Foundation and is on the Board of Trustees for The Paley Center for Media. He also served as COB of the National Association of Theatre Owners, and is currently a member of its Executive Committee. Before that, he was President of the Theatre Owners of America. Mr. Redstone was recently honored with a star on the Hollywood Walk of Fame. Mr. Redstone has devoted himself to a wide variety of civic and community affairs efforts, contributing over $150 million to worthy charities.

Murray Gell-Mann, Ph.D., is a Distinguished Fellow at the Santa Fe Institute as well as the Robert Andrews Millikan Professor Emeritus at the California Institute of Technology. In 2010, he was appointed Presidential Professor of physics and medicine at USC. In 1969 he received the Nobel Prize in physics for his work on the theory of elementary particles.  He is the author of The Quark and the Jaguar.

The goal of the USC Center for Applied Molecular Medicine is the development of novel treatment strategies for cancer.  The Center was implemented to enable multiple disciplines to work on treatment and the care of patients with cancer.  The program includes the clinical care of patients at the USC Westside Cancer Center and has team members with expertise spanning cancer biology, biochemistry, molecular biology, bioinformatics, computer science, electrical engineering, bioorganic chemistry, physics and applied mathematics.

SOURCE USC Center for Applied Molecular Medicine
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
2. MD Anderson Cancer Center joins Actinium Pharmaceuticals (API) Multicenter Actimab-A Trial
3. New UCLA Engineering research center to revolutionize nanoscale electromagnetic devices
4. Center will create self-powered health monitoring devices
5. Allergan Opens New Research and Development Center in Bridgewater, New Jersey
6. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
7. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
8. New Physician Joins Dallas Based Fertility Center
9. The Law Office of Roger G. Worthington, P.C. - Longtime Supporter of the Pacific Meso Center - Donates $100,000 for Mesothelioma Research
10. Breathe Better With Clarity Allergy Center
11. InVigor® Canola Supports Langdon Day Care Center with More for Everyone Award
Post Your Comments:
(Date:11/23/2015)... Calif., Nov. 23, 2015   Ceres, Inc . ... today financial results for the fiscal year ended August ... --> --> During ... forage and feed products with a better balance of ... signed distribution agreements with several leading crop input providers ...
(Date:11/23/2015)... ... November 23, 2015 , ... Shimadzu ... of its Nexera UC Unified Chromatography system. The award from R&D magazine recognizes ... products of the year in the analytical and testing category. R&D Magazine chose ...
(Date:11/23/2015)... 2015 The royalty-free a ... to develop daclatasvir for 112 low- and m ... --> --> The Medicines Patent Pool ... medicine, signing an agreement with Bristol-Myers Squibb for daclatasvir, a ... genotypes of the HCV virus.  The royalty-free licence will enable ...
(Date:11/23/2015)... 23, 2015 biochar market ... 2015, and it is expected to grow with a ... driving the growth of the global market include improved ... of biochar, increased government initiatives and stringent environmental regulations, ... stringent environment regulations are the key drivers for the ...
Breaking Biology Technology:
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/17/2015)... 2015 Paris from 17 ... Paris from 17 th until 19 ... innovation leader, has invented the first combined scanner in the ... same scanning surface. Until now two different scanners were required: one ... capture both on the same surface. This innovation is ...
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
Breaking Biology News(10 mins):